Pages that link to "Q37051667"
Jump to navigation
Jump to search
The following pages link to Possible mechanisms of disease development in tuberous sclerosis (Q37051667):
Displaying 43 items.
- mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis (Q24294367) (← links)
- mTOR signaling in tumorigenesis (Q28252695) (← links)
- Ophthalmic manifestations of tuberous sclerosis: a review (Q30248841) (← links)
- A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits (Q30597707) (← links)
- Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. (Q33579032) (← links)
- Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis. (Q33790613) (← links)
- Cutaneous manifestations of tuberous sclerosis (Q33908340) (← links)
- Pediatric low-grade gliomas (Q34051368) (← links)
- The PTEN-PI3K pathway: of feedbacks and cross-talks (Q34828662) (← links)
- Co2/Erbium:YAG/Dye laser combination: an effective and successful treatment for angiofibromas in tuberous sclerosis. (Q35066662) (← links)
- Epileptogenic but MRI-normal perituberal tissue in Tuberous Sclerosis Complex contains tuber-specific abnormalities (Q35248484) (← links)
- Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex. (Q35532932) (← links)
- Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex (Q35546651) (← links)
- Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex (Q35748464) (← links)
- Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis (Q36595635) (← links)
- The pathogenesis and imaging of the tuberous sclerosis complex (Q37139373) (← links)
- Population-based study of baseline ethanol consumption and risk of incident essential tremor (Q37194534) (← links)
- Genetic testing for paediatric neurological disorders (Q37325077) (← links)
- Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors (Q37355543) (← links)
- Tuberous sclerosis complex: a brave new world? (Q37678112) (← links)
- Vascular involvement in tuberous sclerosis (Q37709196) (← links)
- Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective. (Q37758485) (← links)
- The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective (Q37838317) (← links)
- mTOR signaling in neural stem cells: from basic biology to disease (Q38057633) (← links)
- Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. (Q38066584) (← links)
- Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms (Q38080737) (← links)
- Subependymal giant cell astrocytoma: current concepts, management, and future directions (Q38189289) (← links)
- Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex. (Q38207541) (← links)
- Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications (Q39745229) (← links)
- Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up (Q41990498) (← links)
- Giant pilomatricoma in a patient with tuberous sclerosis, both diagnosed in the adult life (Q42583271) (← links)
- Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex (Q43241190) (← links)
- Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported (Q43862708) (← links)
- Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation (Q44136131) (← links)
- New-onset cardiac rhabdomyoma beyond infancy in a patient with tuberous sclerosis complex. (Q48159649) (← links)
- Giant nasal mass causing feeding difficulty in tuberous sclerosis (Q48665019) (← links)
- Mammalian Target of Rapamycin Inhibitor Induced Complete Remission of a Recurrent Subependymal Giant Cell Astrocytoma in a Patient Without Features of Tuberous Sclerosis Complex (Q48869488) (← links)
- Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex. (Q52326182) (← links)
- Subependymal giant cell astrocytoma with oncocytic change. (Q55463525) (← links)
- Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery (Q59126224) (← links)
- Establishment of a Regional Interdisciplinary Medical System for Managing Patients with Tuberous Sclerosis Complex (TSC) (Q59329066) (← links)
- Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family (Q64114838) (← links)
- Long-Term Exposure and Safety of a Novel Topical Rapamycin Cream for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex: Results From a Single-Center, Open-Label Trial (Q93151886) (← links)